Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.
Joachim Ermer
Advertisement
Joachim Ermer is head of Analytical Lifecycle Management Chemistry Frankfurt at Sanofi.
Articles by Joachim Ermer
Drawing on practical experience, the authors examine key questions and answers about various aspects relating to the enhanced approach for analytical procedure lifecycle management.
Three hypothetical analytical target profiles (ATPs) are provided, reflecting the current thinking of the the European Federation of Pharmaceutical Industries and Associations Analytical Lifecycle Management Team.
Advertisement
Latest Updated Articles
Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>Published: March 2nd 2023 | Updated:
Analytical Procedure Lifecycle Management: Current Status and OpportunitiesPublished: December 2nd 2018 | Updated:
Three Examples of Hypothetical ATPsPublished: December 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
5
